Plasma-Activated Medium Selectively Kills Glioblastoma Brain Tumor Cells by Down-Regulating a Survival Signaling Molecule, AKT Kinase
Plasma Medicine · 2011
DOI: 10.1615/plasmamed.2012006275 ↗Kurz gefasst
Fachartikel in der Zeitschrift Plasma Medicine, 2011. Verfasst von Hiromasa Tanaka und 7 weiteren Autor:innen. Die Arbeit wurde bisher 309-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Tanaka, H., Mizuno, M., Ishikawa, K., Nakamura, K., Kajiyama, H., Kano, H., Kikkawa, F., & Hori, M. (2011). Plasma-Activated Medium Selectively Kills Glioblastoma Brain Tumor Cells by Down-Regulating a Survival Signaling Molecule, AKT Kinase. Plasma Medicine. https://doi.org/10.1615/plasmamed.2012006275
Vancouver
Tanaka H, Mizuno M, Ishikawa K, Nakamura K, Kajiyama H, Kano H, et al. Plasma-Activated Medium Selectively Kills Glioblastoma Brain Tumor Cells by Down-Regulating a Survival Signaling Molecule, AKT Kinase. Plasma Medicine. 2011. doi:10.1615/plasmamed.2012006275
BibTeX
@article{Tanaka2011,
author = {Tanaka, Hiromasa and Mizuno, Masaaki and Ishikawa, Kenji and Nakamura, Kae and Kajiyama, Hiroaki and Kano, Hiroyuki and Kikkawa, Fumitaka and Hori, Masaru},
title = {Plasma-Activated Medium Selectively Kills Glioblastoma Brain Tumor Cells by Down-Regulating a Survival Signaling Molecule, AKT Kinase},
journal = {Plasma Medicine},
year = {2011},
doi = {10.1615/plasmamed.2012006275}
}
EUVIMED